نتایج جستجو برای: high dose cytarabine

تعداد نتایج: 2292508  

Journal: :Blood 2013
Christian Gisselbrecht

In this issue of Blood, Matasar and colleagues report the results of salvage treatments with anti-CD20 ofatumumab in combination with ifosfamide, carboplatinum, etoposide (ICE) or dexamethasone, high-dose cytarabine, cisplatin (DHAP) in relapsed refractory diffuse large B-cell lymphoma (DLBCL) before transplantation. They conclude that replacing rituximab with ofatumumab in second-line therapy ...

Journal: :Haematologica 2015
Renato Bassan Arianna Masciulli Tamara Intermesoli Ernesta Audisio Giuseppe Rossi Enrico Maria Pogliani Vincenzo Cassibba Daniele Mattei Claudio Romani Agostino Cortelezzi Consuelo Corti Anna Maria Scattolin Orietta Spinelli Manuela Tosi Margherita Parolini Filippo Marmont Erika Borlenghi Monica Fumagalli Sergio Cortelazzo Andrea Gallamini Rosa Maria Marfisi Elena Oldani Alessandro Rambaldi

Developing optimal radiation-free central nervous system prophylaxis is a desirable goal in acute lymphoblastic leukemia, to avoid the long-term toxicity associated with cranial irradiation. In a randomized, phase II trial enrolling 145 adult patients, we compared intrathecal liposomal cytarabine (50 mg: 6/8 injections in B-/T-cell subsets, respectively) with intrathecal triple therapy (methotr...

Journal: :Blood 2014
Arne Kolstad Anna Laurell Mats Jerkeman Kirsten Grønbæk Erkki Elonen Riikka Räty Lone Bredo Pedersen Annika Loft Trond Velde Bogsrud Eva Kimby Per Boye Hansen Unn-Merete Fagerli Herman Nilsson-Ehle Grete Fossum Lauritzsen Anne Kristine Lehmann Christer Sundstrom Marja-Liisa Karjalainen-Lindsberg Elisabeth Ralfkiaer Mats Ehinger Jan Delabie Hans Bentzen Jukka Schildt Kamelia Kostova-Aherdan Henrik Frederiksen Peter de Nully Brown Christian H Geisler

The main objective of the MCL3 study was to improve outcome for patients not in complete remission (CR) before transplant by adding (90)Y-ibritumomab-tiuxetan (Zevalin) to the high-dose regimen. One hundred sixty untreated, stage II-IV mantle cell lymphoma patients <66 years received rituximab (R)-maxi-CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone) alternating with R-...

Journal: :Blood 1992
P A Cassileth E Lynch J D Hines M M Oken J J Mazza J M Bennett P B McGlave M Edelstein D P Harrington M J O'Connell

The Eastern Cooperative Oncology Group (ECOG) conducted a randomized trial in patients less than or equal to 65 years old (median, 44 years) to determine whether increasing the intensity of postremission therapy in acute myeloid leukemia (AML) would improve the outcome. After uniform induction therapy, patients in complete remission (CR) who were less than 41 years old and who had a histocompat...

Journal: :Cancer Cell International 2021

Abstract Background Primary breast double-hit lymphoma (PB-DHL) is a rare, highly aggressive malignancy that poses challenges regarding accurate diagnosis and selecting optimal treatment regimens. Methods We retrospectively reviewed 48 cases of patients diagnosed with PB-DHL in six academic centres between June 2014 2020 China. Study-specific data were recorded, including options, therapeutic e...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید